Xebra Brands Ltd. (XBRA) AI Stock Analysis

Xebra Brands Ltd.

(CNQX:XBRA)

Select Model

Rating:48.75Neutral

Action:N/A

Date:03/29/25

Xebra Brands Ltd. scores 48.75, reflecting significant financial struggles, including high liabilities and negative cash flows. However, recent strategic corporate events, such as market expansions and regulatory achievements, provide potential growth opportunities. The technical analysis suggests upward momentum but warns of overbought conditions.

Positive Factors

Market ExpansionEntering the U.S. CBD market with a strategic partner enhances Xebra's market presence in North America, tapping into the world's largest hemp and CBD market, which is crucial for long-term growth.

Negative Factors

Financial InstabilityPersistent financial instability, marked by negative cash flow and declining equity, poses a risk to Xebra's ability to sustain operations and invest in growth opportunities.

Xebra Brands Ltd. (XBRA) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 375.91K
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.1
Beta (1Y): -1.20
Revenue Growth: ―
EPS Growth: ―
Country: Canada
Employees: 0
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Xebra Brands Ltd. Business Overview & Revenue Model

Company Description

Operating within Canada, Xebra Brands Ltd. is involved in the entire lifecycle of cannabis products, from their cultivation and processing to manufacturing, innovative design, and distribution. Their diverse product lineup features cannabis-infused b...

How the Company Makes Money

Xebra Brands Ltd. generates revenue through the cultivation, production, and sale of cannabis products. The company's primary revenue streams include the sale of cannabis flowers, oils, and infused products to both medical and recreational consumers....

Xebra Brands Ltd. Technical Analysis

Technical Analysis SentimentNegative

Last Price0.01

Price Trends

50DMA0.01Negative

100DMA0.01Negative

200DMA0.01Negative

Market Momentum

MACD-0.00Neutral

STOCH100.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:XBRA, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of -0.00 indicates Neutral momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:XBRA.

Xebra Brands Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:XBRA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:XBRA	49Neutral	CAD 420.72K	-0.14	-610.58%	―	―	―
TSE:XCX	41Neutral	CAD 258.28K	-1.03	5.55%	―	―	―
TSE:CNTR	37Underperform	CAD 579.89K	-2.13	13.65%	―	―	36.39%

* Healthcare Sector Average

Performance Comparison

TSE:XBRA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:XBRA	Xebra Brands Ltd.	0.01	0.00	0.00%
TSE:MLCL	Molecule Holdings Inc.	0.01	0.00	0.00%
TSE:GHG	Global Hemp	0.02	0.00	0.00%
TSE:CNTR	Centr Brands Corp.	0.05	0.00	0.00%
TSE:XCX	Greenrise Global Brands Inc	0.01	-0.00	-33.33%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Mar 29, 2025

Xebra Brands Ltd. AI Stock Analysis